<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2584032F-79DE-4183-A760-727AE45C4F32"><gtr:id>2584032F-79DE-4183-A760-727AE45C4F32</gtr:id><gtr:firstName>Yvonne</gtr:firstName><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9900061"><gtr:id>F84FC790-12FC-4467-A0CA-79A8E653BCC5</gtr:id><gtr:title>The structural basis of recognition and signalling in the cellular immune response</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9900061</gtr:grantReference><gtr:abstractText>The cells in a multicellular organism, such as a human, need to communicate with each other to co-ordinate their functions. Direct cell-cell communication is achieved through the interactions of specialized receptor molecules protruding from the cell surface. One vital role that a sub-set of these receptors must fulfill is to allow identification of infected or otherwise malfunctional (for example cancerous) cells. Such cells must be identified rapidly and eliminated to preserve the health of the whole organism. Clearly this killing function must be very carefully controlled so that healthy cells are not eliminated; conversely it is important that infected cells do not evade detection. The specialized cells of the immune system perform this task with T cells taking a leading role in detecting infection and triggering the appropriate response. The surface of a T cell bears multiple copies of a membrane spanning molecule termed the T cell receptor (TCR). Each T cell carries only one example of the many possible variants of this receptor. It is through the interactions of the TCR with a second set of receptors (called MHC molecules) on the surface of its target cells that T cells distinguish between those cells that are healthy and those that are infected. TCRs are designed to bind to MHC molecules but only bind sufficiently strongly to trigger the T cell to take action when the MHC molecule is combined with a fragment (antigen) derived from the molecules of an invading pathogen. The immune system generates a spectrum of TCRs to try to insure that at least one is competent to bind a particular antigen-MHC combination, trigger the T cell and hence mobilize the immune response. The details of TCR-antigen-MHC interactions can provide an explanation for why certain individuals mount strong, successful immune responses to particular diseases while others are more susceptible, how certain pathogens (or cancers) evade the immune response and what triggers self destructive auto immune diseases. This programme aims to address these questions by providing in atomic level detail the 3D-structures of clinically relevant TCR-antigen-MHC complexes. This information should guide the design of new immuno-therapies and vaccines.</gtr:abstractText><gtr:technicalSummary>This programme aims to address the structural basis of cell-cell recognition events that govern the response of T cells to antigen presenting cells. The current application details research proposals for a second quinquenium that build directly on the achievements of the group during the first funding period (1999-2004). The intention is to continue to contribute to a well established network of interdisciplinary research, in particular to interface with the molecular, cellular and clinical studies of the MRC Human Immunology Unit (Director Prof. A. McMichael, Weatherall Institute of Molecular Medicine, Oxford) and the research programmes of A. van der Merwe (MRC Reader, Dunn School of Pathology, Oxford) and C. O?Callaghan (MRC Senior Clinical Research Fellow, Nuffield Department of Clinical Medicine). Opportunities to contribute to translational research will be actively pursued. 

In the proposal T cell receptor (TCR) mediated recognition and signaling provides a common theme overarching three biomedically focused sections:

i) Recognition of viral epitopes presented by MHC class I. Questions relating to viral escape and vaccine design will be addressed.
ii) Cross-reactivity in TCR - MHC class II recognition. The role of structural mimicry will be investigated and the possible structural factors contributing to auto-immune disease will be assessed.
iii) TCR based recognition of non-classical MHC class I like molecules including CD1-glycolipid complexes. The mode and specificity of TCR interaction with non-peptide antigens will be analysed.

In the short to medium term the methodological aspects of the programme will remain focused on production of soluble molecules and/or complexes and their analysis by primarily x-ray crystallographic and surface plasmon resonance based techniques. In the fourth section of the programme we set ourselves the major long-term objective of providing structural detail for the next level of complexity in the multi-molecular signaling assemblies required for TCR signaling. We anticipate that this may require close interplay with cryo-electron microscopy methodologies.</gtr:technicalSummary><gtr:fund><gtr:end>2009-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1614286</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Immunology Unit</gtr:department><gtr:description>Structure-function analyses with groups in MRC HIU</gtr:description><gtr:id>11BBD5A6-4E14-4D78-96A2-D4CFB80D905F</gtr:id><gtr:impact>16388312, 16557259, 16520393, 16803907, 16951352, 16672288, 17109469, 17355862, 17485514, 17466984, 17825624, 17878911, 18083574, 18275829, 18593354, 18513924, 18953350, 18453560, 19303388, 19307587, 19412183, 19390419, 19465480, 19715696</gtr:impact><gtr:outcomeId>5D590107D3A-1</gtr:outcomeId><gtr:partnerContribution>Functional studies and reagents to underpin our structural studies i.e. interdisciplinary collaborations</gtr:partnerContribution><gtr:piContribution>Structural studies (crystal structures) and/or general structural/molecular perspective</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>DH Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6096F1C6-FB96-4F3F-A978-1023339A43E5</gtr:id><gtr:impact>Public lecture, informed public understanding

No subsequent impact</gtr:impact><gtr:outcomeId>07293362DDE</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Programme Grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>10976</gtr:fundingRef><gtr:id>2C1F756B-67D9-4412-B4F4-E5A90C5E8B24</gtr:id><gtr:outcomeId>A074A4F37010</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant (renewal)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0900084</gtr:fundingRef><gtr:id>DDC404B1-F629-4320-BABC-31952E1A1836</gtr:id><gtr:outcomeId>BE2689F9C400</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Crystal structures deposited in PDB</gtr:description><gtr:id>C704E9B0-8270-4621-9F0A-AD22D3931817</gtr:id><gtr:impact>ongoing biomedical research</gtr:impact><gtr:outcomeId>UzULzn8GqZF</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PDB</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>efficient vectors and protocols for transient high level expression of secreted proetins in mammalian cells</gtr:description><gtr:id>EEC680C6-B646-41A6-86EF-4DAA5CCE4F5F</gtr:id><gtr:impact>many citations of our original paper (PMID: 17001101) and requests for vectors</gtr:impact><gtr:outcomeId>94FEDAA4917</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>pLex</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/17001101</gtr:url><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>848C2DB6-FEEC-476C-9D11-BB41569BBF3F</gtr:id><gtr:title>Rational development of high-affinity T-cell receptor-like antibodies.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3bd7185a0698864c4440b2dbd1fed93"><gtr:id>a3bd7185a0698864c4440b2dbd1fed93</gtr:id><gtr:otherNames>Stewart-Jones G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>C8352F81E32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F024E079-6AC1-4F16-8054-9314954E5A07</gtr:id><gtr:title>A time- and cost-efficient system for high-level protein production in mammalian cells.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53cd70c2c528ff9abb11a980a68b8eec"><gtr:id>53cd70c2c528ff9abb11a980a68b8eec</gtr:id><gtr:otherNames>Aricescu AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>66221273D51</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D4219E7-E654-40BA-8C4B-09DC49C20E95</gtr:id><gtr:title>Roquin binds microRNA-146a and Argonaute2 to regulate microRNA homeostasis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6af624579414ccd17cfee013d2316987"><gtr:id>6af624579414ccd17cfee013d2316987</gtr:id><gtr:otherNames>Srivastava M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56caf6d769c2c2.69280392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCF5C655-B451-4F0F-A0AA-4D8ACC94AA39</gtr:id><gtr:title>MHC class II proteins and disease: a structural perspective.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5e3a7dc78f1cd307cc16ee3d61ffa18"><gtr:id>d5e3a7dc78f1cd307cc16ee3d61ffa18</gtr:id><gtr:otherNames>Jones EY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>2D3661CF894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA20A1D5-AC30-4434-A7B6-A1677CEADA55</gtr:id><gtr:title>Combined sequence-based and genetic mapping analysis of complex traits in outbred rats.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4256295b8f159ec8613c3533a81ab24"><gtr:id>e4256295b8f159ec8613c3533a81ab24</gtr:id><gtr:otherNames>Rat Genome Sequencing and Mapping Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15318_28_23708188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F1031CC-D757-45A1-8CBF-B38FFD611037</gtr:id><gtr:title>Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d074abc03c715ec0a4b00eddac6d3810"><gtr:id>d074abc03c715ec0a4b00eddac6d3810</gtr:id><gtr:otherNames>Stewart-Jones GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15318_28_23161907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E406326C-9311-4ABA-816B-309B9940D183</gtr:id><gtr:title>Some lessons from the systematic production and structural analysis of soluble (alpha)(beta) T-cell receptors.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0410f5fd9b779a7cd94e46d263d446ba"><gtr:id>0410f5fd9b779a7cd94e46d263d446ba</gtr:id><gtr:otherNames>van Boxel GI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>662DD20B555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52A37165-9F89-492E-B44C-E7DEE91BA13F</gtr:id><gtr:title>Humidity control as a strategy for lattice optimization applied to crystals of HLA-A*1101 complexed with variant peptides from dengue virus.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef361cc945b0f0ed648474bcfc22a0d3"><gtr:id>ef361cc945b0f0ed648474bcfc22a0d3</gtr:id><gtr:otherNames>Chotiyarnwong P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>2DCE8DA66CB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE3AD840-C8A1-4B96-BA5D-D8B7D5A360E6</gtr:id><gtr:title>Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4356eab1246e34581d070464d8892cd2"><gtr:id>4356eab1246e34581d070464d8892cd2</gtr:id><gtr:otherNames>Bowden TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>pm_15318_28_23025485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0736F666-638F-49EE-85FB-64B7DBCF9BFE</gtr:id><gtr:title>Glycoprotein structural genomics: solving the glycosylation problem.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68a136b0edbb71d5410f0ee7a4e92009"><gtr:id>68a136b0edbb71d5410f0ee7a4e92009</gtr:id><gtr:otherNames>Chang VT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>48F10CD5BDA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E818B65-1896-4FC1-AEFD-F2E8F84DE623</gtr:id><gtr:title>Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03e0374cf703d528f0919afff7ec8853"><gtr:id>03e0374cf703d528f0919afff7ec8853</gtr:id><gtr:otherNames>Gadola SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>66D58A4203B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C14171F-7963-41A2-8775-756C4FCEA75F</gtr:id><gtr:title>Disruption of alpha-mannosidase processing induces non-canonical hybrid-type glycosylation.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a18a28d8b9384d80bc97c8f0b04d80ca"><gtr:id>a18a28d8b9384d80bc97c8f0b04d80ca</gtr:id><gtr:otherNames>Crispin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>1113D1682C3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F96527F-FD94-4201-AF39-4DDDD2405672</gtr:id><gtr:title>Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49a45bc2b3cb7e3f4064a9dce2caec9a"><gtr:id>49a45bc2b3cb7e3f4064a9dce2caec9a</gtr:id><gtr:otherNames>Silk JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>B44E6FFC253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1CA8C34-B6AC-455F-B709-C31E31AC1D89</gtr:id><gtr:title>The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a3d14f806abdcc1cebb3b589a32041b"><gtr:id>7a3d14f806abdcc1cebb3b589a32041b</gtr:id><gtr:otherNames>McCarthy C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>D90204E9626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EE0564A-AEE6-428E-8758-F088E248E599</gtr:id><gtr:title>Building meaningful models of glycoproteins.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a18a28d8b9384d80bc97c8f0b04d80ca"><gtr:id>a18a28d8b9384d80bc97c8f0b04d80ca</gtr:id><gtr:otherNames>Crispin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>7995D7436E1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B2F9996-7CB7-4DA9-8D71-B628C0C78420</gtr:id><gtr:title>Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway.</gtr:title><gtr:parentPublicationTitle>Glycobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a18a28d8b9384d80bc97c8f0b04d80ca"><gtr:id>a18a28d8b9384d80bc97c8f0b04d80ca</gtr:id><gtr:otherNames>Crispin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0959-6658</gtr:issn><gtr:outcomeId>7BAABA4D4D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AEF49E4-F69A-441B-BB4D-E375237AD61C</gtr:id><gtr:title>Genetics. First-class control of HIV-1.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14eeb8916c21a02f9a4f13433a8408c8"><gtr:id>14eeb8916c21a02f9a4f13433a8408c8</gtr:id><gtr:otherNames>McMichael AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_15318_28_21148380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF0B7F1A-4CE8-46C8-A7A3-083133A8DCBC</gtr:id><gtr:title>First steps towards effective methods in exploiting high-throughput technologies for the determination of human protein structures of high biomedical value.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eafd81fb2fff553b9918a8057b672855"><gtr:id>eafd81fb2fff553b9918a8057b672855</gtr:id><gtr:otherNames>Banci L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>60898578AB0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3B80391-71E9-4B14-B68F-7E24D1001B68</gtr:id><gtr:title>A human embryonic kidney 293T cell line mutated at the Golgi alpha-mannosidase II locus.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a18a28d8b9384d80bc97c8f0b04d80ca"><gtr:id>a18a28d8b9384d80bc97c8f0b04d80ca</gtr:id><gtr:otherNames>Crispin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>0D59CB32D6D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3EC31E5-B979-4573-A70B-81674801C68B</gtr:id><gtr:title>The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cd735d2c7ec2a06f5c43d6198a3ebae"><gtr:id>7cd735d2c7ec2a06f5c43d6198a3ebae</gtr:id><gtr:otherNames>Ishizuka J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>AA8BB4A0FEE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9211301B-BB32-4016-A03C-0267A4A35292</gtr:id><gtr:title>Molecular analysis of receptor protein tyrosine phosphatase mu-mediated cell adhesion.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53cd70c2c528ff9abb11a980a68b8eec"><gtr:id>53cd70c2c528ff9abb11a980a68b8eec</gtr:id><gtr:otherNames>Aricescu AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>6CE204FB42D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60F0E524-9225-43FF-93E3-15F95F332A4A</gtr:id><gtr:title>The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognition.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd9cdb41b63b19f1798d264e04b29a65"><gtr:id>dd9cdb41b63b19f1798d264e04b29a65</gtr:id><gtr:otherNames>Hourigan CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>A61F5E03611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DB9125A-6CD4-4026-999E-B0FE44C8EFB2</gtr:id><gtr:title>A closer look at CD1d molecules: new horizons in studying NKT cells.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e39180eb6888ee1d2e14ccf9b4a5bb"><gtr:id>e0e39180eb6888ee1d2e14ccf9b4a5bb</gtr:id><gtr:otherNames>Stronge VS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>A673EC0C5C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6854DF7-A887-4EA1-B92C-94CC81314968</gtr:id><gtr:title>Biology of CD1- and MR1-restricted T cells.</gtr:title><gtr:parentPublicationTitle>Annual review of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdd7cfa24aca2bdff2a40d8bc27c2f1e"><gtr:id>cdd7cfa24aca2bdff2a40d8bc27c2f1e</gtr:id><gtr:otherNames>Salio M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0732-0582</gtr:issn><gtr:outcomeId>54647922734e53.83402324</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28880AD5-8ACB-4744-9820-74E8F22CA58D</gtr:id><gtr:title>Ca2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptor.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54116faae123c2097a55cead7889d479"><gtr:id>54116faae123c2097a55cead7889d479</gtr:id><gtr:otherNames>Chen JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>ZZDFVQrjzo1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3564CF4F-F677-430D-AC86-E701B0E84D86</gtr:id><gtr:title>The crystal structure of H-2D(b) complexed with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermediate.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4fe29dbdaa932824e1ba08f4801c948"><gtr:id>e4fe29dbdaa932824e1ba08f4801c948</gtr:id><gtr:otherNames>Glithero A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>DA3F83D6452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B204327E-F1F1-40DF-A562-BFA040B4E278</gtr:id><gtr:title>Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f5491b386d455aa4032571d48e83937"><gtr:id>6f5491b386d455aa4032571d48e83937</gtr:id><gtr:otherNames>Gillespie GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>436F09695E4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA1141EA-F19A-4EA7-9182-EFDF094A09CB</gtr:id><gtr:title>Extracellular regulation of type IIa receptor protein tyrosine phosphatases: mechanistic insights from structural analyses.</gtr:title><gtr:parentPublicationTitle>Seminars in cell &amp; developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e45552f74935c2b55405cf4aea87bed"><gtr:id>6e45552f74935c2b55405cf4aea87bed</gtr:id><gtr:otherNames>Coles CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1084-9521</gtr:issn><gtr:outcomeId>54647922e7bad9.57784629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>848FABD3-E248-4E9C-99E0-26AB9DF21EFF</gtr:id><gtr:title>Functional characteristics of HIV-1 subtype C compatible with increased heterosexual transmissibility.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4553f674658302853c0fe2bda8bd491a"><gtr:id>4553f674658302853c0fe2bda8bd491a</gtr:id><gtr:otherNames>Walter BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>D7121351137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DDA84D0-3E42-4C2D-8A81-AF275F533E7C</gtr:id><gtr:title>Structural basis of fibrillar collagen trimerization and related genetic disorders.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aca0ce77c25bf1fca6395f22aa21d7e8"><gtr:id>aca0ce77c25bf1fca6395f22aa21d7e8</gtr:id><gtr:otherNames>Bourhis JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_15318_28_23001006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3F91541-E57D-4B50-918D-1BE4EFB644D6</gtr:id><gtr:title>T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ed5289aaeeb07f31ea1141b71d9e736"><gtr:id>2ed5289aaeeb07f31ea1141b71d9e736</gtr:id><gtr:otherNames>Harkiolaki M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>7C19F138EAD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A767DF3-A6CC-44E1-BBC2-40B33D886968</gtr:id><gtr:title>Crystal structure and binding properties of the CD2 and CD244 (2B4)-binding protein, CD48.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97380c30e502ef92d34ee0d551434bb5"><gtr:id>97380c30e502ef92d34ee0d551434bb5</gtr:id><gtr:otherNames>Evans EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>0C3A8E39349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6B43626-1B00-47CE-8862-33D9FF349295</gtr:id><gtr:title>Initiation of T cell signaling by CD45 segregation at 'close contacts'.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68a136b0edbb71d5410f0ee7a4e92009"><gtr:id>68a136b0edbb71d5410f0ee7a4e92009</gtr:id><gtr:otherNames>Chang VT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58989df46ca3b5.95166846</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F3778E7-380E-4E50-9F15-B57CE3A443C3</gtr:id><gtr:title>Production of cell surface and secreted glycoproteins in mammalian cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90d6514d22869015fa3a132781b28749"><gtr:id>90d6514d22869015fa3a132781b28749</gtr:id><gtr:otherNames>Seiradake E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>56caf6d7e49636.91913833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A1A2E53-3B0B-4AE0-BD11-E0A5461857A4</gtr:id><gtr:title>Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71247b3e4da43217946b0d0e25e8029d"><gtr:id>71247b3e4da43217946b0d0e25e8029d</gtr:id><gtr:otherNames>Iversen AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>B68D3BDEB7A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BB6C8D6-3BDB-433C-976F-67AF1A6E6777</gtr:id><gtr:title>Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7271d887d655ab8bf8e880119ff2237"><gtr:id>a7271d887d655ab8bf8e880119ff2237</gtr:id><gtr:otherNames>Tenzer S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>65B63017386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26C1CF68-F182-4394-B832-57D59CCFCE94</gtr:id><gtr:title>Structural basis for extracellular cis and trans RPTPs signal competition in synaptogenesis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e45552f74935c2b55405cf4aea87bed"><gtr:id>6e45552f74935c2b55405cf4aea87bed</gtr:id><gtr:otherNames>Coles CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>546479233ff776.65053248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EC4AC78-7CD0-4B60-8007-26E4AFB568E0</gtr:id><gtr:title>Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a18a28d8b9384d80bc97c8f0b04d80ca"><gtr:id>a18a28d8b9384d80bc97c8f0b04d80ca</gtr:id><gtr:otherNames>Crispin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>8D4B82B0E46</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>305499F8-9064-4EB8-8E0F-46467B39808C</gtr:id><gtr:title>Dissection of the multiple sclerosis associated DR2 haplotype.</gtr:title><gtr:parentPublicationTitle>Journal of autoimmunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b46adfbb9a619dc3b1c361ec173f153"><gtr:id>7b46adfbb9a619dc3b1c361ec173f153</gtr:id><gtr:otherNames>Etzensperger R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0896-8411</gtr:issn><gtr:outcomeId>C77A4791337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2DEA8D6-FA39-4AD3-BBDB-9CCDBF80A5D2</gtr:id><gtr:title>Unusual molecular architecture of the machupo virus attachment glycoprotein.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4356eab1246e34581d070464d8892cd2"><gtr:id>4356eab1246e34581d070464d8892cd2</gtr:id><gtr:otherNames>Bowden TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>151FA238B6E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3901F585-E302-4166-82C9-E8D0464C8077</gtr:id><gtr:title>Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68719213bb1c312f00046e91edb42c17"><gtr:id>68719213bb1c312f00046e91edb42c17</gtr:id><gtr:otherNames>Koch M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>21D56B3A4CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>154CE1E0-90D7-48B1-9E53-43699F66BA05</gtr:id><gtr:title>An alternative conformation of the T-cell receptor alpha constant region.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0410f5fd9b779a7cd94e46d263d446ba"><gtr:id>0410f5fd9b779a7cd94e46d263d446ba</gtr:id><gtr:otherNames>van Boxel GI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>c4exhCawtCk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D89B54E7-E3FA-489B-BD86-9817281AD548</gtr:id><gtr:title>Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a77fb0f2314c03a96d151763fa8313dc"><gtr:id>a77fb0f2314c03a96d151763fa8313dc</gtr:id><gtr:otherNames>Friese MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>DB5EC29138E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45FB50BB-4977-4398-96D5-2E5EED2168FD</gtr:id><gtr:title>Structure of a tyrosine phosphatase adhesive interaction reveals a spacer-clamp mechanism.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53cd70c2c528ff9abb11a980a68b8eec"><gtr:id>53cd70c2c528ff9abb11a980a68b8eec</gtr:id><gtr:otherNames>Aricescu AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>B18EE07962E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D15016BF-4A1C-4539-B76A-EE724FD511C3</gtr:id><gtr:title>T cell receptors get back to basics.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5e3a7dc78f1cd307cc16ee3d61ffa18"><gtr:id>d5e3a7dc78f1cd307cc16ee3d61ffa18</gtr:id><gtr:otherNames>Jones EY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>F44FE9AAD24</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2D584D9-0E5D-4A6D-B890-4BAB0182416D</gtr:id><gtr:title>Structural and functional aspects of lipid binding by CD1 molecules.</gtr:title><gtr:parentPublicationTitle>Annual review of cell and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49a45bc2b3cb7e3f4064a9dce2caec9a"><gtr:id>49a45bc2b3cb7e3f4064a9dce2caec9a</gtr:id><gtr:otherNames>Silk JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1081-0706</gtr:issn><gtr:outcomeId>29B7EB6C077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>634E12E5-86EC-4E52-A321-0939AD6321F6</gtr:id><gtr:title>Crystal structure of the GluR2 amino-terminal domain provides insights into the architecture and assembly of ionotropic glutamate receptors.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94cecf5eee5ee2651ba0267133ed5d73"><gtr:id>94cecf5eee5ee2651ba0267133ed5d73</gtr:id><gtr:otherNames>Clayton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_15318_18_19651138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23CA0E1E-C237-44DB-932A-2CA321A73E82</gtr:id><gtr:title>Neuropilins lock secreted semaphorins onto plexins in a ternary signaling complex.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/886b3e6aa85103d0bc4dce2eeb2374a7"><gtr:id>886b3e6aa85103d0bc4dce2eeb2374a7</gtr:id><gtr:otherNames>Janssen BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_15318_28_23104057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73DD7833-9B57-416F-8A6B-E3FEEAD0D349</gtr:id><gtr:title>Structural basis of semaphorin-plexin signalling.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/886b3e6aa85103d0bc4dce2eeb2374a7"><gtr:id>886b3e6aa85103d0bc4dce2eeb2374a7</gtr:id><gtr:otherNames>Janssen BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>HfKAPZgVTLx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3C1B804-4A95-4F60-88F3-0E8B37B6F638</gtr:id><gtr:title>Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbd5fc47723096b3e0f2a3c6fbdc73b2"><gtr:id>fbd5fc47723096b3e0f2a3c6fbdc73b2</gtr:id><gtr:otherNames>McMahon RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>p8qV6vQMbfC</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9900061</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>